Double Down: Two Coalitions Push for Enhanced Funding for FDA

For the first time since the user fee program was created, industry-supported lobbying groups have formed to help win a bigger budget for FDA. Stakeholders are optimistic they'll be successful.

On the face of it, it’s a bizarre concept: the drug industry working as part of a broad-based coalition with patient groups and former government health officials to try to get more money for the Food & Drug Administration.

But what might be more bizarre is that it’s happened twice: since the start of the negotiations surrounding the reauthorization...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet